Nasdaq • SMMT • US86627T1088
As of Oct 22, 2026, ORTEX estimated 27.2% of free float sold short, 5.9 days to cover, cost to borrow 0.69%. Sign up for live short interest data.
This page tracks how heavily Summit Therapeutics Inc. (Nasdaq:SMMT) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Summit Therapeutics Inc. (Nasdaq: SMMT) has a market capitalization of $13.07B. Last close $16.33 (as of 2026-11-09); 52-week range $12.07 to $29.23. ORTEX data as of 2026-10-22: short interest was 27.17% of free float, 5.9 days to cover and the average cost to borrow was 0.69%. Sign up for live short interest data.
